Concepedia

Deepa Jeyakumar

DJ

Statistics

Publications

28

Citations

2.2K

H-Index

18

Active since

2002

Affiliations

University of California, Irvine(Current)

The University of Texas MD Anderson Cancer Center

Moffitt Cancer Center

Dana-Farber Cancer Institute

University of California San Diego

Deepa Jeyakumar is an author at University of California, Irvine specializing in medicine, hematologic malignancy therapy, and chemotherapy.

Publications per year

2002–2025

28

Publications

28

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole et al. · The Lancet · 2021 · 769 citations · Full text

Medicine, Hematology, Oncology +9

Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

Mark R. Litzow, Zhuoxin Sun, Ryan J. Mattison et al. · New England Journal of Medicine · 2024 · 215 citations · Full text

Medicine, Hematology, Oncology +16

A Sensitive, Quantitative Assay for Human Immunodeficiency Virus Type 1 Integration

Una O’Doherty, William J. Swiggard, Deepa Jeyakumar et al. · Journal of Virology · 2002 · 211 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study

David A. Sallman, Monzr M. Al Malki, Adam S. Asch et al. · Journal of Clinical Oncology · 2023 · 171 citations · Full text

Medicine, Immunology, Oncology +17

Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results

Naval Daver, Paresh Vyas, Suman Kambhampati et al. · Journal of Clinical Oncology · 2023 · 121 citations · Full text

Medicine, Immunology, Pharmacology +17

1–5 of 28